Suppr超能文献

角膜移植术后行散光矫正型人工晶状体植入术治疗白内障的效果。

Outcomes of cataract surgery with toric intraocular lens implantation after keratoplasty.

机构信息

From the Department of Translational Medicine, University of Ferrara, Ferrara, Italy (Pellegrini, Furiosi, Yu, Gardeli, Busin, Bovone, Spena); Department of Ophthalmology, Ospedali Privati Forlì "Villa Igea," Forlì, Italy (Pellegrini, Furiosi, Yu, Gardeli, Busin, Bovone, Spena); Istituto Internazionale per la Ricerca e Formazione in Oftalmologia (IRFO), Forlì, Italy (Pellegrini, Furiosi, Yu, Busin, Bovone, Spena); Department of Ophthalmology, Magna Graecia University of Catanzaro, Catanzaro, Italy (Giannaccare, Scuteri); General Hospital of Athens "G. Gennimatas," Athens, Greece (Gardeli).

出版信息

J Cataract Refract Surg. 2022 Feb 1;48(2):157-161. doi: 10.1097/j.jcrs.0000000000000730.

Abstract

PURPOSE

To evaluate the efficacy and predictability of cataract extraction with toric intraocular lens (IOL) implantation after deep anterior lamellar keratoplasty (DALK) or mushroom penetrating keratoplasty (PK).

SETTING

Villa Igea Hospital, Forlì, Italy.

DESIGN

Prospective case series.

METHODS

Toric IOL implantation was offered to patients with cataract, corneal astigmatism >1.5 diopters (D) and regular central corneal topography after complete suture removal. Phacoemulsification was performed through a 2.4 mm scleral tunnel and an enVista monofocal toric MX60T or Eyecryl monofocal toric IOL was inserted in the capsular bag. Main outcome measures were uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest refraction, total prediction error, and IOL misalignment.

RESULTS

37 consecutive patients who had previously undergone either DALK (n = 27, 73%) or 2-piece mushroom PK (n = 10, 27%) were included. All patients completed the 6-month follow-up. The mean toric IOL power was 5.3 ± 1.1 D. Both UDVA and CDVA significantly improved (from 1.02 ± 0.27 to 0.46 ± 0.31 logMAR and from 0.65 ± 0.27 to 0.11 ± 0.12 logMAR, respectively; P < .001). 20 eyes (54%) reached UDVA ≥20/40, whereas 35 eyes (95%) reached a CDVA ≥20/40. Final refractive astigmatism was 0.93 ± 0.87 D, with 35 eyes (95%) within 2 D. Prediction error was ≤1 D in 18 eyes (49%). Absolute IOL misalignment was 3.3 ± 3.5 degrees.

CONCLUSIONS

Toric IOL implantation in postkeratoplasty eyes allowed reduction of refractive astigmatism to predictably low levels with concomitant improved visual outcomes.

摘要

目的

评估白内障摘除联合散光型人工晶状体(IOL)植入术治疗穿透性角膜移植术后(PK)或深板层角膜移植术后(DALK)后角膜散光的疗效和可预测性。

设置

意大利福里维拉吉亚医院。

设计

前瞻性病例系列。

方法

对完全拆线后角膜散光>1.5 屈光度(D)和角膜规则性中央地形图的白内障患者,提供散光型 IOL 植入。通过 2.4mm 巩膜隧道行超声乳化白内障吸除术,并在囊袋内植入 EnVista 单焦点 Toric MX60T 或 Eyecryl 单焦点 Toric IOL。主要观察指标为未矫正远视力(UDVA)、矫正远视力(CDVA)、角膜曲率、总预测误差和 IOL 偏位。

结果

共纳入 37 例患者,其中 27 例(73%)曾行 DALK,10 例(27%)行 2 片式蘑菇 PK。所有患者均完成 6 个月随访。平均散光 IOL 度数为 5.3±1.1D。UDVA 和 CDVA 均显著改善(从 1.02±0.27 降至 0.46±0.31logMAR 和从 0.65±0.27 降至 0.11±0.12logMAR,P<0.001)。20 只眼(54%)达到 UDVA≥20/40,35 只眼(95%)达到 CDVA≥20/40。最终等效球镜屈光度为 0.93±0.87D,35 只眼(95%)在 2D 以内。18 只眼(49%)预测误差≤1D。IOL 绝对偏位为 3.3±3.5 度。

结论

穿透性角膜移植或深板层角膜移植术后,白内障摘除联合散光型 IOL 植入术可显著降低屈光性散光,提高视力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验